Here's How Much $100 Invested In Regeneron Pharmaceuticals 15 Years Ago Would Be Worth Today

Regeneron Pharmaceuticals (NASDAQ:REGN) has outperformed the market over the past 15 years by 18.57% on an annualized basis producing an average annual return of 30.32%. Currently, Regeneron Pharmaceuticals has a market capitalization of $110.13 billion.

Buying $100 In REGN: If ...

Full story available on Benzinga.com